Biotech Layoffs
Biotech Layoffs Continue in 2024: Spero and Pfizer Among Latest to Cut Workforce
Biotech layoffs, Spero, Pfizer, workforce reduction, 2024 layoffs, pharmaceutical industry, job cuts.
Spero Therapeutics Slashes 39% of Workforce Following Phase 2 Antibiotic Trial Failure
Spero Therapeutics, antibiotic trial failure, workforce reduction, biotech layoffs, cash runway extension
Marinus Pharmaceuticals to Reduce Workforce and Explore Strategic Alternatives Following Disappointing Trial Results
Marinus Pharmaceuticals, workforce reduction, strategic alternatives, Ztalmy trial, pharmaceutical industry, biotech layoffs
Pharmaceutical Giants J&J, Bayer, and Pfizer Announce Layoffs Affecting Nearly 500 Employees
Layoffs, Pharmaceutical Industry, Johnson & Johnson, Bayer, Pfizer, Biotech Layoffs, Workforce Reduction
Astellas Gene Therapies to Close South San Francisco Manufacturing Facility
Astellas Gene Therapies, South San Francisco, manufacturing facility closure, gene therapy, biotech layoffs
Boundless Bio Implements Strategic Workforce Reduction to Enhance Operational Efficiency
Boundless Bio, workforce reduction, San Diego, operational efficiency, biotech layoffs
FibroGen to Shrink US Workforce by 75% Following More Late-Stage Fails
FibroGen, workforce reduction, pamrevlumab, clinical trials, biotech layoffs, pancreatic cancer drug
Fierce Biotech Layoff Tracker 2024: GlycoMimetics Cuts 80% of Company; Anokion Undergoes Cuts
Biotech Layoffs, GlycoMimetics, Anokion, Pharmaceutical Industry, Job Cuts, Cost Reduction
Fierce Biotech Layoff Tracker 2024: Industry-Wide Job Cuts Continue
Biotech Layoffs, 2024, MEI Pharma, Rapt Therapeutics, Industry Cuts